Locations:
Search
Evidence mounts that these diabetes and obesity drugs may protect eyes, not endanger them
Use of GLP-1s and improving cardiovascular health lowers risk of hematologic malignancies
Complications highlight need to exercise caution when managing geriatric patients
Findings show greater reduction in CKD progression, kidney failure than GLP-1RAs
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Provider vigilance and patient education are key for management
Findings establish overweight/obesity as a modifiable risk factor for cardiovascular disease
Two major trials promise key progress against the last unaddressed major risk factor
Advertisement
Advertisement